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O B J E C T I V E S The aim of this study was to assess the relationship of the extent of subclinical
atherosclerosis measured by coronary artery calciﬁcation (CAC) to the extent of second-hand tobacco
smoke (SHTS) exposure in asymptomatic people who never smoked.
B A C KG ROUND An association between SHTS and CAC was recently reported in a single study, but
the quantitative aspects of the relationship are not known.
METHOD S A cohort of 3,098 never smokers 40 to 80 years of age, enrolled in the FAMRI-IELCAP
(Flight Attendant Medical Research Institute International Early Lung Cancer Action Program) screening
program, completed a SHTS questionnaire, and had a low-dose nongated computed tomography scan.
The questionnaire provided a quantitative score for total SHTS exposure, as well as separately as a child
and as an adult at home and at work; 4 categories of exposure to SHTS were identiﬁed (minimal, low,
moderate, and high exposure). CAC was graded using a previously validated ordinal scale score that
ranged from 0 to 12. Logistic regression analysis of the prevalence and ordered logistic regression
analysis of the extent of CAC were performed to assess the independent contribution of SHTS adjusted
for age, sex, diabetes, hypercholesterolemia, hypertension, and renal disease. Linear and quadratic
regression analyses of CAC and SHTS were performed.
R E S U L T S The prevalence of CAC was 24.3% (n  754) and was signiﬁcantly higher in those with
more than minimal SHTS exposure compared with those with minimal SHTS exposure (26.4% vs. 18.5%,
p  0.0001). The adjusted odds ratios for CAC prevalence were 1.54 (95% conﬁdence interval: 1.17 to
2.20) for low SHTS exposure, 1.60 (95% conﬁdence interval: 1.21 to 2.10) for moderate exposure, and 1.93
(95% conﬁdence interval: 1.49 to 2.51) for high exposure. The association of the extent of SHTS with the
extent of CAC was conﬁrmed by the adjusted odds ratio (p  0.0001).
CONC L U S I O N S The presence and extent of CAC were associated with extent of SHTS exposure
even when adjusted for other risk factors for CAC, suggesting that SHTS exposure causes CAC. (J Am
Coll Cardiol Img 2013;6:651–7) © 2013 by the American College of Cardiology Foundation
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he link between second-hand tobacco
smoke exposure (SHTS) and clinical coronary
artery disease (CAD) has been extensively
investigated. Hirayama (1,2) reported the as-
sociation of CAD with SHTS exposure in his
cohort studies of 91,540 never-smoking women in
Japan in 1984. In 1985, Garland et al. (3) also
showed the association in 695 lifetime never smok-
ers in California. Subsequently, additional cohort
and case-control studies addressing the association of
SHTS and CAD were performed (4,5), including
See page 658
studies that convincingly demonstrated that the
increased risk due to SHTS persisted even when
other risk factors for CAD were considered (6–8).
Based on this accumulated evidence, the Surgeon
General’s 2006 report (5) concluded that the data
supported a causal association between SHTS and
CAD mortality and morbidity.
An association between SHTS with
subclinical atherosclerosis as evidenced by
coronary artery calcification (CAC) was
first demonstrated in a recent report (9). It
showed that CAC scores were signifi-
cantly higher in SHTS-exposed than in non-
exposed individuals, even after adjustment for
other cardiovascular risk factors. CAC mea-
surement using computed tomography (CT)
(10–16) is increasingly being used for CAD
risk stratification and has been shown to be
superior to risk-based algorithms (13). It has
received class IIa status in the 2010 American College of
Cardiology Foundation/American Heart Association
Guideline for Assessment of Cardiovascular Risk in
Asymptomatic Adults for evaluation of intermediate risk
people (16).
In this report, we address the prevalence and
extent of subclinical atherosclerosis manifesting by
CAC with the extent of SHTS on low-dose non-
gated CT in a large cohort of asymptomatic people
who had never smoked. Although most CAC
studies have used gated scans, we have previously
demonstrated that low-dose nongated CT scans
obtained when screening for lung cancer provided
prognostic CAD information similar to that of
gated acquisitions in a cohort of smokers (17).
M E T H O D S
Cohort. We identified all men and women who had
se
ynrolled in the FAMRI-IELCAP (Flight Atten-ant Medical Research Institute International Early
ung Cancer Action Program) CT screening pro-
ram from 2005 to 2012 who had no history of and
ere asymptomatic for CAD. This program was
stablished to assess the association of SHTS expo-
ure with pulmonary and cardiovascular diseases by
rospectively enrolling never smokers and assessing
he extent of CAC on demonstrated low-dose CT
cans. All 3,098 participants were never smokers,
efined by the accepted convention as having
moked 100 cigarettes in their lifetime. Consent
as obtained from all participants according to
ealth Insurance Portability and Accountability
ct–compliant protocols, approved by the institu-
ional review boards of the collaborating institu-
ions. Once consent was obtained, all participants
ompleted a background form. It asked the partic-
pant whether he or she had a known diagnosis of
iabetes, hypertension, hypercholesterolemia, or re-
al disease. For this study, we selected all partici-
ants who were 40 to 80 years of age; 49% of the
articipants were white, 49% were Asian (2% were
ther), and 82% had completed high school.
Low-dose baseline CT scan. A low-dose nongated,
oncontrast CT scan was performed on each indi-
idual at 120 kVp and 60 mA and collimation
f 1.25 mm. Images were obtained from the lung
pices to the bases in a single breath-hold at
aximum inspiration. The CT readings used in
his study were performed at the co-ordinating
enter on high-resolution monitors. CAC assess-
ent was done using standard mediastinal settings
width, 350 Hounsfield units; level, 50 Hounsfield
nits). The presence of CAC in the main, left
nterior descending, circumflex, and right coronary
rteries were categorized as absent, mild, moderate,
r severe and scored as 0, 1, 2, or 3, respectively
17,18). CAC was classified as mild calcification if
ess than one-third of the length of the entire artery
ontaining calcification (CAC  1), moderate if
one-third to two-thirds (CAC  2), and severe if
more than two-thirds of the artery showed calcifi-
cation (CAC 3). Each participant received a total
CAC score that was the sum of the CAC score for
each of the coronary arteries, ranging from 0 to 12.
The CAC scores were divided into 3 categories of
increasing severity: 0, 1 to 3, and 4 to 12 (17).
SHTS exposure score. All participants completed a
background questionnaire about SHTS exposure
before age 18 as a child and after age 18 as an adult
at home and at work (Table 1). The answers
determined the permission status, duration ofA B B R E V I A T I O N S
A N D A C R O N YM S
CAC coronary artery
calcification
CAD coronary artery disea
CI confidence interval
CT computed tomograph
OR odds ratio
SHTS second-handSHTS exposure (years), daily intensity of the SHTS
v2
2
t
m
h
s
S
r
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 6 , N O . 6 , 2 0 1 3
J U N E 2 0 1 3 : 6 5 1 – 7
Yankelevitz et al.
CAC and Second-Hand Tobacco Smoke in Never Smokers
653exposure (packs per day) for each of these life
exposures (as a child and as an adult at home and at
work). The permission status was 1.0 if smoking
was allowed anywhere, 0.5 if smoking was re-
stricted, or 0.0 if smoking was not permitted. The
exposure duration was the sum of the years that the
participant was exposed to SHTS. The daily expo-
sure intensity was determined as a child and as an
adult at work and at home: as a child, 1.0 pack per
day if household members smoked; as an adult at
work, 1.5 packs per day if others smoked at work; as
an adult at home if household members smoked, it
was 1.5 if more than 25 cigarettes per day, 1.0 if 15
to 24 cigarettes per day, 0.35 if 15 cigarettes per
day, 0.70 if number of cigarettes smoked was
unknown. Total SHTS exposure score was the
product of permission status exposure duration
daily exposure intensity for each life exposure (as a
child and as an adult at home and at work).
The total SHTS exposure score was the sum of
these SHTS life exposure scores divided by 204, the
maximum possible SHTS score for an 80-year-old
enrollee. The total SHTS exposure score ranged
from 0.0 to 0.70. The exposure was classified as
minimal if the total SHTS exposure score was
0.005 (n  821), and these never smokers pro-
Table 1. Second-Hand Tobacco Smoke Questions
A. Second-hand smoke exposure: childhood
1. Did anyone in your house smoke in the home when you
were under 18? No/Yes
If yes, was smoking allowed inside the house? Not permitted,
restricted, allowed anywhere.
2. Did your mother/primary caregiver smoke when you were
younger than 7 years of age? No/Yes
3. Did your mother/primary caregiver smoke when you were
7 to 18 years of age? No/Yes
4. Did anyone else besides your mother/primary caregiver
smoke in the home when you were younger than 18 years
of age? No/Yes
B. Second-hand smoke exposure: adult at home
5. Do you currently live with a smoker? No/Yes
6. After 18 years of age, did you live with someone for
1 year who smoked in your presence? No/Yes
If yes, at what ages did you live with someone who smoked
around you and how much did they smoke? (Give details
for the last 4, starting with most recent ﬁrst.)
Age range, amount, smoking not permitted, restricted,
allowed anywhere.
C. Second-hand smoke exposure: adult at work
7. After 18 years of age, did you work for 1 year at a
worksite where smoking was allowed? No/Yes
If yes, give details on the last 4 places, starting with the most
recent ﬁrst.
Age range, job, smoking not permitted, restricted, allowed
anywhere.ided the comparison group for the remaining,277 never smokers with higher SHTS scores. The
,277 never smokers were equally divided into
ertiles: low (0.005  SHTS 0.093, n  759),
oderate (0.093  SHTS 0.18, n  759), and
igh (SHTS0.18, n 759) (Fig. 1). The average
cores for minimal, low, moderate, and extensive
HTS exposure were 0.0047, 0.053, 0.13, and 0.29,
espectively.
Statistical analysis. All statistical analyses were per-
formed using SAS version 9.2 (SAS Institute, Cary,
North Carolina). For graphs, we used PASW
Statistics 18 (formerly SPSS) (Chicago, Illinois).
Frequencies and descriptive statistics were obtained
for all the variables. Univariate analysis of the
prevalence of any CAC, SHTS exposure score, and
other variables was performed using Kruskal-
Wallis, chi-square, and Fisher exact tests. Logistic
regression analysis was used to address the relation-
ship of the prevalence of CAC to SHTS exposure
categories while adjusting for other risk factors of
CAC: age, sex, diabetes, hypercholesterolemia, hy-
pertension, and renal disease, as reported on the
background questionnaire. The extent of CAC was
analyzed for the 3 categories of CAC (0, 1 to 3, 4
to 12) using ordered logistic regression analysis
adjusting for the other risk factors of CAC.
R E S U L T S
The prevalence of CAC (CAC  0) was higher for
those with higher than minimal SHTS exposure
than those with minimal SHTS exposure (26.4% vs.
18.5%, p  0.0001) (Table 2). This was also the
case for the CAC categories 1 to 3 and 4 to 12.
Participants with more than minimal SHTS expo-
sure were older (55 vs. 53 years of age), more
frequently women (64.5% vs. 46.2%), and more
frequently had diabetes, hypercholesterolemia,
and hypertension than those with minimal SHTS
exposure.
The prevalence of CAC for men and women by
decades of age is given in Table 3. For every decade,
the prevalence of CAC was significantly higher for
those with more than minimal SHTS exposure
compared with those with minimal exposure, for
both men (p  0.0001) and women (p  0.04).
The prevalence of any CAC increased signifi-
cantly (p 0.0001) with increasing SHTS exposure
categories of minimal (18.5%), low (22.1%), mod-
erate (22.1%), and high (35.1%).
Multivariate logistic regression analysis of the
contributors to the prevalence of CAC revealed
odds ratios (ORs) of 1.5 (95% confidence interval
moderate,
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654[CI]: 1.2 to 2.0; p  0.002) for low SHTS
exposure, 1.6 (95% CI: 1.2 to 2.1; p  0.0008) for
moderate exposure, and 1.9 (95% CI: 1.5 to 2.5;
p 0.0001) for high SHTS exposure. Table 4 gives
the ORs for the SHTS exposure categories (low,
moderate, high) when adjusted for the other risk
factors for CAC (age, diabetes, hypercholesterol-
emia, hypertension, and renal disease). The ad-
justed OR was 1.5 (95% CI: 1.2 to 2.0; p  0.002),
1.6 (95% CI: 1.2 to 2.1; p  0.0008), and 1.9 (95%
CI: 1.5 to 2.5; p  0.000) for low, moderate, and
high SHTS exposure, respectively, thus demon-
strating that SHTS exposure was an independent
predictor of the prevalence of CAC. To determine
whether the SHTS exposure categories were inde-
pendent predictors of the extent of CAC (0, 1 to 3,
4 to 12), ordered logistic regression analysis was
performed adjusting for the other risk factors of
CAC as before, and the results were consistent with
the results from the multivariate logistic regression
analysis. The prevalence of any CAC increased
monotonically with SHTS score.
The total SHTS score was a significant indepen-
dent predictor of the prevalence of CAC (p 
0.0001) after adjusting for the other risk factors of
age, diabetes, hypercholesterolemia, hypertension,
and renal disease in the logistic regression analysis.
Replacing the total SHTS score by the childhood
SHTS exposure score, it was a significant indepen-
dent predictor of CAC (p  0.03). Similarly,
SHTS exposure as an adult at home exposure alone
Individual SHTS Exposure Scores of Participants
Minimal Low Moderate High
SHTS Exposure Scores for 3,098 Never Smokers
nd tobacco smoke (SHTS) exposure score distribution for the
kers according to their exposure category (minimal, low,
high).was a significant independent predictor of CAC(p  0.02), as was the adult at work exposure (p 
0.0007).
D I S C U S S I O N
This study is the first to document the significant
quantitative relationship in never smokers between
SHTS exposure and the prevalence and extent of
subclinical atherosclerosis manifested by CAC. It
also showed that when considering SHTS exposure
in childhood, as an adult at home, and as an adult
at work separately, each was an independent pre-
dictor of the prevalence of CAC. Moreover, it
establishes that with increasing SHTS exposure,
there is an increase in the extent of CAC and that
a significant dose relationship existed. In this study, the
ORs for SHTS are as high as or higher than decade of
age, diabetes, hypertension, hypercholesterolemia, and
renal disease, all well-established risk factors for CAD.
The present study reinforces previous studies showing
the increased risk of CAD from SHTS and particularly
with increasing SHTS exposure.
There was no evaluation of the association of
CAC and SHTS exposure until the Heinz Nixdorf
Recall Study, a prospective population-based cohort
of asymptomatic participants undergoing gated CT
scans for CAC (9). Their study reported an OR of
1.38 for the presence of CAC in 379 never smokers
with SHTS exposure compared with 1,387 never
smokers with no SHTS exposure adjusted for age,
Table 2. Distribution of Age, Sex, CAC, Diabetes,
Hypercholesterolemia, Hypertension, and
Renal Disease in 3,098 Asymptomatic Never Smokers
by SHTS Exposure Category
SHTS Exposure Category
Minimal
(n  821)
More Than
Minimal
(n  2,277) p Value
CAC
Any 18.5 (152) 26.4 (602) 0.0001
0 81.5 (669) 73.6 (1,675) 0.0001
1–3 13.9 (114) 21.1 (480)
4–12 4.6 (38) 5.4 (122)
Sex
Male 53.8 (442) 35.5 (809) 0.0001
Female 46.2 (379) 64.5 (1,468)
Median age, yrs 53 55 0.0001
Diabetes 3.5 (29) 5.4 (122) 0.04
Hypercholesterolemia 16.1 (132) 29.2 (666) 0.0001
Hypertension 15.8 (130) 23.3 (530) 0.0001
Renal disease 1.7 ( 14) 1.4 ( 32) 0.54
Values are % (n).SH
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655sex, and other major cardiovascular risk factors.
SHTS exposure was categorized as present/absent
at work, at home, or other places as an adult in their
study. In our study, a detailed, prospectively admin-
istered SHTS exposure questionnaire permitted
evaluation of the quantitative relationship between
the extent of SHTS and the extent of CAC and
suggested that the association might be stronger
than previously estimated.
SHTS exposure is an underappreciated major
global health issue. A large global study showed
that 40% of children, 33% of male never smokers,
and 35% of female never smokers in 2004 were
exposed to SHTS (19). The estimated worldwide
mortality was 605,000 deaths, 1% of the world’s
mortality: 379,000 from CAD, 165,000 from lower
respiratory infections, 36,900 from asthma, and
24,000 from lung cancer. Among the deaths,
women accounted for 47%, men for 26%, and
children for 28%. The remarkable number attribut-
able to cardiovascular disease mandates more vig-
Table 3. Prevalence of CAC, Separately by SHTS Exposure Categ
Ex
Men
Minimal SHTS
(n  442)
More Than Minimal
(n  809)
Age, yrs
40–49 6.5 (11/170) 18.16 (51/281)
50–59 25.0 (37/148) 35.5 (108/304)
60–69 27.2 (22/81) 56.5 (95/168)
70–80 46.5 (20/43) 69.6 (39/56)
Values are % coronary artery calciﬁcation (n/N).
Abbreviations as in Table 2.
Table 4. Logistic Regression Analysis of the Prevalence of
CAC in 3,098 Asymptomatic Never Smokers Using Indicator
Variables for Having Low, Moderate, or High SHTS
Exposure, Adjusted for Other Determinants
OR 95% CI p Value
SHTS categories
Low 1.5 1.2–2.0 0.002
Moderate 1.6 1.2–2.1 0.0008
Extensive 1.9 1.5–2.5 0.0001
Other risk factors
Age per decade 1.1 1.1–1.1 0.0001
Male 2.5 2.0–3.0 0.0001
Diabetes 1.9 1.3–2.7 0.0008
High cholesterol 1.6 1.3–1.9 0.0001
Hypertension 1.4 1.2–1.8 0.001
Renal disease 1.3 0.7–2.6 0.45CI  conﬁdence interval; OR  odds ratio; other abbreviations as in Table 2.orous prevention of exposure and identification and
treatment of those with early stages of the disease.
A number of reports have consistently documented
factors contributing to cardiovascular disease that are
associated with SHTS exposure (5,20–23). Among
these are platelet activation and aggregation, endothelial
dysfunction, flow-mediated dilation, arterial stiffness,
carotid intima-media thickening, dysfunctional endo-
thelial progenitor cells, increased endothelial micro-
particles, abolished endothelial progenitor cell che-
motaxis, and an increase in the following: white blood
cells, C-reactive protein, homocysteine, oxidative
stress, insulin resistance, heart and blood pressure, and
infarct size. As stated in the Surgeon General’s report
(5), current exposure to SHTS appears to be more
armful than past exposure and previous studies also
uggest a higher risk of CAD from high-intensity expo-
ure. Also, the magnitude of the effect of SHTS on
latelet aggregation and endothelial dysfunction has been
hown to be nonlinear (5), which may be the explanation
or the strong effect of the high SHTS exposure.
Study limitations. Visual CAC scores from non-
gated CT scans were used rather than conventional
Agatston scoring obtained from gated CT scans.
However, we had previously shown that the visual
CAC score was a powerful predictor of death
caused by cardiovascular disease in smokers (17).
Moreover, misclassification of CAC because of the
visual scoring would not bias the association with
SHTS, barring the unlikely possibility that misclas-
sification would differ among the exposure catego-
ries. Also, the use of ordinal values for the visual
CAC scoring rather than the use of the Agatston
score limits quantitative comparison. Another lim-
itation may be the lack of confirmation of the
smoking status by the use of cotinine testing.
However, this test would only confirm the lack of
smoking in the very recent past as opposed to the
, Men and Women, and Decades of Age
t of SHTS Exposure
Women
S Minimal SHTS
(n  379)
More Than Minimal SHTS
(n  1,468)
2.2 (3/138) 8.1 (31/383)
16.7 (23/138) 15.5 (87/562)
30.0 (21/70) 31.4 (130/414)
45.5 (15/33) 56.0 (61/109)ory
ten
SHTlifelong status of being a never smoker (5). The
s
i
N
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656SHTS questionnaire was developed before the start
of the study. It focused on the cumulative damage
over longer intervals of time to examine the ques-
tion of differences in the average intensity of expo-
sure compared with the duration of exposure in
producing chronic injury. The validity of the inten-
sity measures in the questionnaire for actual biolog-
ical exposures was previously documented (5). The
concern that early life exposures may make a con-
tribution to the chronic injury led us to capture
these data to the extent possible, although in this
older cohort, recall of early exposure may not be as
reliable as the recall as an adult. Possible biases of
self-reporting of SHTS were extensively addressed
in the 2006 report. It was recognized that SHTS
exposure is typically underreported. Such underre-
porting is particularly found in prospective studies
such as ours, and this underreporting bias tends to
underestimate the association of SHTS with a
disease, in our case, subclinical atherosclerosis,
rather than to overestimate the association (23).
C O N C L U S I O N S
With the increasing body of evidence linkingter for Health Promotion, Natio-
1
1990;15:827–32.given to its official recognition as an important
independent risk factor. Standard medical history
taking should be broadened to include SHTS ex-
posure. It is critical to recognize that it is an
eminently avoidable risk factor, as evidenced by the
reduction in acute myocardial infarction after im-
plementation of smoke-free laws (24–28). The
ability to document increased cardiovascular risk in
never smokers exposed to SHTS from a low-dose
screening CT scan offers an opportunity for com-
bined early detection and treatment of lung cancer
(29,30), emphysema (31), and cardiovascular dis-
ease (17), the 3 major diseases attributable to SHTS
exposure. Ongoing progress in the development of
gated CT scans at low-dose radiation is the next
step in the routine inclusion of CAC assessment
while screening for lung cancer.
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